Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 4073-98-7 | MDL No. : | MFCD00058680 |
Formula : | C17H22N2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OMHOXRVODFQGCA-UHFFFAOYSA-N |
M.W : | 254.37 | Pubchem ID : | 77690 |
Synonyms : |
|
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.29 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 0.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 84.57 |
TPSA : | 52.04 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.05 cm/s |
Log Po/w (iLOGP) : | 2.83 |
Log Po/w (XLOGP3) : | 3.94 |
Log Po/w (WLOGP) : | 3.69 |
Log Po/w (MLOGP) : | 3.7 |
Log Po/w (SILICOS-IT) : | 4.41 |
Consensus Log Po/w : | 3.71 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.23 |
Solubility : | 0.0148 mg/ml ; 0.0000583 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -4.73 |
Solubility : | 0.00471 mg/ml ; 0.0000185 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -6.16 |
Solubility : | 0.000178 mg/ml ; 0.0000007 mol/l |
Class : | Poorly soluble |
PAINS : | 1.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.79 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302+H312+H332-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | Stage #1: With hydrogenchloride In water at 70℃; Stage #2: With hydrogenchloride In dichloromethane; water at 20℃; for 2 h; Stage #3: With sodium hydroxide In diethyl ether; water |
To a solution of 2,6-dimethylaniline (10.00 g, 0.083 mol) and formaldehyde (4.03 g, 0.054 mol, 0.65 eq. ) was added dilute hydrochloric acid (2.2 ml, 0.1 M). The biphasic solution was stirred at 70 °C overnight. The dark reddish solution was left to cool to ambient temperature and diluted with dichloromethane (15 ml). The minimum amount of concentrated hydrochloric acid (2 ml) was introduced and the solution stirred at room temperature for 2 hours before being filtered. The white salt collected was washed thoroughly with dichloromethane and air-dried. The salt was suspended in diethyl ether (70 ml) and stirred with an aqueous solution of saturated sodium hydroxide until the dissolution of the solid. The aqueous phase was extracted with diethyl ether (2 x 70 ml) and the combined organic phases dried over magnesium sulfate, filtered and concentrated under reduced pressure to give 2a as an orange solid (8.97 g, 86percent). |